Source: Eur Respir J 2008; 32: 244-245



Rating:

Share or cite this content

Citations should be made in the following way:
Polosa, R., Edwards, C. J.. Tacrolimus for antisynthetase syndrome with interstitial lung disease?. Eur Respir J 2008; 32: 244-245

Member's Comments

No comment yet.

Related content which might interest you: Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus Source: Eur Respir J 2008; 31: 213-217 Year: 2008 Rituximab therapy for interstitial lung disease in patients with antisynthetase syndrome Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders? Source: Eur Respir J 2011; 38: 384-391 Year: 2011 Metabolic syndrome in interstitial lung diseases Source: International Congress 2015 – IIPs: orphan Year: 2015 Interstitial lung disease in Sjogren's syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 587s Year: 2002 Idiopathic interstitial pneumonia and connective tissue disorder-related interstitial lung disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=170 Year: 2007 Interstitial lung diseases associated with amyopathic dermatomyositis Source: Eur Respir J 2006; 28: 1005-1012 Year: 2006 Rituximab in the management of idiopathic inflammatory myopathies complicated by interstitial lung disease Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia Source: International Congress 2015 – Treatment of IPF Year: 2015 Air-leak syndrome caused by pleuroparenchymal fibroelastosis after bone marrow transplantation Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Progressive fibrosis is common in patients with Sjögren’s syndrome and Interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Pulmonary involvement in antisynthetase syndrome: more than myopathy Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases Year: 2021 Interstitial lung disease associated with polymyositis-dermatomyositis Source: Eur Respir J 2005; 26: Suppl. 49, 31s Year: 2005 Characterization of interstitial pneumonia associated with clinical amyopathic dermatomyositis Source: International Congress 2015 – Connective tissue disorders Year: 2015 Rituximab treatment of a case of anti-syntetase syndrome with severe interstitial lung disease and acute respiratory failure Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Negative outcome of prednisone in possible idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF clinical Year: 2016 Rituximab in severe, treatment-refractory interstitial lung disease Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Broncho-obstructive syndrome in patients with granulomatous pulmonary diseases. Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD) Source: International Congress 2015 – Connective tissue disorders Year: 2015 Efficacy of switching from cyclosporine A to tacrolimus in patients with refractory CTD-ILD Source: International Congress 2016 – Connective tissue disorders Year: 2016